Overview
Healthcare-focused investment firm managing venture and equity funds.
Founded
1989
Deals ยท 12mo
32
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Altis Labs | Sep 2026Led | $25 MSeries A | |
Leal Therapeutics | Aug 2026Participated | $30 MSeries A | |
TytoCare | Jul 2026Participated | $25 MOther Equity | |
Iswarya Fertility Center | Jul 2026Led | $37 MOther Equity | |
Fore Biotherapeutics | Jul 2026Participated | $67 MSeries D | |
Lycia Therapeutics | Jun 2026Participated | $75 MSeries D | |
TruNativ | Jun 2026Led | $30 MSeries B | |
Accro Bioscience | May 2026Led | $50 MSeries C | |
Windward Bio | May 2026Led | $165 MOther Equity | |
Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026Participated | $50 MSeries A | |
Pam Medical | Apr 2026Participated | $100 MSeries D | |
Nucleus RadioPharma | Apr 2026Led | $50 MOther Equity | |
Altis Labs | Sep 2026Led | $25 MSeries A | |
Leal Therapeutics | Aug 2026Participated | $30 MSeries A | |
TytoCare | Jul 2026Participated | $25 MOther Equity | |
Iswarya Fertility Center | Jul 2026Led | $37 MOther Equity | |
Fore Biotherapeutics | Jul 2026Participated | $67 MSeries D | |
Lycia Therapeutics | Jun 2026Participated | $75 MSeries D | |
TruNativ | Jun 2026Led | $30 MSeries B | |
Accro Bioscience | May 2026Led | $50 MSeries C | |
Windward Bio | May 2026Led | $165 MOther Equity | |
Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026Participated | $50 MSeries A | |
Pam Medical | Apr 2026Participated | $100 MSeries D | |
Nucleus RadioPharma | Apr 2026Led | $50 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 1 |
| Series A | 49 | 45 |
| Series B | 49 | 88 |
| Series C+ | 36 | 102 |
| Other Equity | 31 | 51 |
| Debt | 6 | 5 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '07 | 1 |
| May '07 | 0 |
| Jun '07 | 1 |
| Jul '07 | 0 |
| Aug '07 | 0 |
| Sep '07 | 0 |
| Oct '07 | 0 |
| Nov '07 | 1 |
| Dec '07 | 0 |
| Jan '08 | 0 |
| Feb '08 | 0 |
| Mar '08 | 1 |
| Apr '08 | 0 |
| May '08 | 0 |
| Jun '08 | 0 |
| Jul '08 | 0 |
| Aug '08 | 0 |
| Sep '08 | 0 |
| Oct '08 | 0 |
| Nov '08 | 0 |
| Dec '08 | 0 |
| Jan '09 | 1 |
| Feb '09 | 0 |
| Mar '09 | 0 |
| Apr '09 | 1 |
| May '09 | 0 |
| Jun '09 | 0 |
| Jul '09 | 0 |
| Aug '09 | 1 |
| Sep '09 | 0 |
| Oct '09 | 0 |
| Nov '09 | 0 |
| Dec '09 | 0 |
| Jan '10 | 0 |
| Feb '10 | 0 |
| Mar '10 | 0 |
| Apr '10 | 3 |
| May '10 | 0 |
| Jun '10 | 1 |
| Jul '10 | 2 |
| Aug '10 | 2 |
| Sep '10 | 4 |
| Oct '10 | 1 |
| Nov '10 | 0 |
| Dec '10 | 1 |
| Jan '11 | 0 |
| Feb '11 | 2 |
| Mar '11 | 0 |
| Apr '11 | 0 |
| May '11 | 1 |
| Jun '11 | 1 |
| Jul '11 | 1 |
| Aug '11 | 2 |
| Sep '11 | 0 |
| Oct '11 | 3 |
| Nov '11 | 2 |
| Dec '11 | 2 |
| Jan '12 | 1 |
| Feb '12 | 0 |
| Mar '12 | 3 |
| Apr '12 | 1 |
| May '12 | 0 |
| Jun '12 | 2 |
| Jul '12 | 0 |
| Aug '12 | 3 |
| Sep '12 | 0 |
| Oct '12 | 3 |
| Nov '12 | 3 |
| Dec '12 | 1 |
| Jan '13 | 0 |
| Feb '13 | 1 |
| Mar '13 | 0 |
| Apr '13 | 1 |
| May '13 | 1 |
| Jun '13 | 1 |
| Jul '13 | 1 |
| Aug '13 | 1 |
| Sep '13 | 3 |
| Oct '13 | 1 |
| Nov '13 | 0 |
| Dec '13 | 2 |
| Jan '14 | 3 |
| Feb '14 | 2 |
| Mar '14 | 2 |
| Apr '14 | 5 |
| May '14 | 4 |
| Jun '14 | 0 |
| Jul '14 | 1 |
| Aug '14 | 1 |
| Sep '14 | 4 |
| Oct '14 | 3 |
| Nov '14 | 0 |
| Dec '14 | 4 |
| Jan '15 | 2 |
| Feb '15 | 0 |
| Mar '15 | 2 |
| Apr '15 | 3 |
| May '15 | 1 |
| Jun '15 | 2 |
| Jul '15 | 1 |
| Aug '15 | 3 |
| Sep '15 | 5 |
| Oct '15 | 3 |
| Nov '15 | 3 |
| Dec '15 | 2 |
| Jan '16 | 5 |
| Feb '16 | 2 |
| Mar '16 | 1 |
| Apr '16 | 1 |
| May '16 | 1 |
| Jun '16 | 1 |
| Jul '16 | 1 |
| Aug '16 | 4 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 1 |
| Dec '16 | 2 |
| Jan '17 | 4 |
| Feb '17 | 2 |
| Mar '17 | 1 |
| Apr '17 | 2 |
| May '17 | 4 |
| Jun '17 | 4 |
| Jul '17 | 3 |
| Aug '17 | 1 |
| Sep '17 | 2 |
| Oct '17 | 3 |
| Nov '17 | 3 |
| Dec '17 | 4 |
| Jan '18 | 3 |
| Feb '18 | 2 |
| Mar '18 | 2 |
| Apr '18 | 4 |
| May '18 | 2 |
| Jun '18 | 1 |
| Jul '18 | 2 |
| Aug '18 | 3 |
| Sep '18 | 1 |
| Oct '18 | 5 |
| Nov '18 | 3 |
| Dec '18 | 0 |
| Jan '19 | 1 |
| Feb '19 | 4 |
| Mar '19 | 3 |
| Apr '19 | 3 |
| May '19 | 0 |
| Jun '19 | 2 |
| Jul '19 | 1 |
| Aug '19 | 3 |
| Sep '19 | 3 |
| Oct '19 | 1 |
| Nov '19 | 2 |
| Dec '19 | 2 |
| Jan '20 | 3 |
| Feb '20 | 1 |
| Mar '20 | 2 |
| Apr '20 | 4 |
| May '20 | 1 |
| Jun '20 | 1 |
| Jul '20 | 5 |
| Aug '20 | 11 |
| Sep '20 | 7 |
| Oct '20 | 6 |
| Nov '20 | 5 |
| Dec '20 | 4 |
| Jan '21 | 5 |
| Feb '21 | 1 |
| Mar '21 | 8 |
| Apr '21 | 4 |
| May '21 | 5 |
| Jun '21 | 4 |
| Jul '21 | 3 |
| Aug '21 | 10 |
| Sep '21 | 8 |
| Oct '21 | 2 |
| Nov '21 | 2 |
| Dec '21 | 4 |
| Jan '22 | 2 |
| Feb '22 | 3 |
| Mar '22 | 1 |
| Apr '22 | 1 |
| May '22 | 2 |
| Jun '22 | 4 |
| Jul '22 | 3 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 2 |
| Nov '22 | 3 |
| Dec '22 | 0 |
| Jan '23 | 4 |
| Feb '23 | 1 |
| Mar '23 | 4 |
| Apr '23 | 1 |
| May '23 | 2 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 3 |
| Sep '23 | 5 |
| Oct '23 | 5 |
| Nov '23 | 3 |
| Dec '23 | 1 |
| Jan '24 | 4 |
| Feb '24 | 4 |
| Mar '24 | 3 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 1 |
| Jul '24 | 3 |
| Aug '24 | 1 |
| Sep '24 | 2 |
| Oct '24 | 2 |
| Nov '24 | 2 |
| Dec '24 | 3 |
| Jan '25 | 4 |
| Feb '25 | 1 |
| Mar '25 | 3 |
| Apr '25 | 1 |
| May '25 | 3 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 3 |
| Sep '25 | 7 |
| Oct '25 | 1 |
| Nov '25 | 2 |
| Dec '25 | 3 |
| Jan '26 | 4 |
| Feb '26 | 1 |
| Mar '26 | 5 |
| Apr '26 | 8 |
| May '26 | 2 |
| Jun '26 | 2 |
| Jul '26 | 3 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 463 |
| Manufacturing | 23 |
| AI & Machine Learning | 18 |
| Space & Frontier Tech | 16 |
| Consumer & Lifestyle | 12 |
| Data, Analytics & IT | 7 |
| Enterprise Software | 5 |
| E-Commerce & Retail | 5 |
| Networks, Cloud & Communication | 5 |
| Professional Services | 5 |
| Developer Tools | 5 |
| Fintech | 3 |
| Food & Agriculture | 3 |
| Social & Community Platforms | 3 |
| Hardware & Robotics | 2 |
| Travel & Hospitality | 1 |
| Marketing & Advertising | 1 |
| Media & Entertainment | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 4 |
| $5M-$10M | 10 |
| $10M-$25M | 57 |
| $25M-$50M | 121 |
| $50M-$100M | 158 |
| $100M-$250M | 103 |
| $250M-$500M | 11 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 9 of 9 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 333 |
| Europe | 50 |
| China | 33 |
| Israel | 26 |
| Canada | 10 |
| India | 8 |
| Hong Kong | 3 |
| Australia | 1 |
| Russian Federation | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| RA Capital Management | 62 |
| Cormorant Asset Management | 40 |
| Lilly Asia Ventures | 34 |
| Logos Capital | 34 |
| Foresite Capital | 31 |
| Surveyor Capital | 30 |
| Novo Holdings | 28 |
| SR One | 28 |
| Janus Henderson Investors | 26 |
| Versant Ventures | 26 |
| Alexandria Venture Investments | 25 |
| Deerfield Management | 25 |
| Rock Springs Capital | 25 |
| Wellington Management | 25 |
| Fidelity Management & Research Company | 24 |
| Venrock | 24 |
| Vivo Capital | 24 |
| HBM Healthcare Investments | 23 |
| Osage University Partners | 22 |
| 5AM Ventures | 21 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 173 | 37% |
| Participating | 292 | 63% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 79 | 46% |
| Co-led | 94 | 54% |
Team
Venture Partner
Partner & Senior Managing Director, Asia
Partner
Chief Compliance Officer
Derivatives Trader
Co-Head of Private Equity and Managing Partner
Senior Trader
Partner & Co-Founder
Venture Partner
Private Equity Partner
Managing Partner
Chairman and Interim Chief Executive Officer